Name: Bristol-Myers Squibb Company (BMY) Earnings Call
Start: 2026-10-29

Recent quarters

Latest 4 quarters

Beat in 4 of 4 · beat then fell 0 · average move ⁦±4.6%⁩

Quarter	EPSReported / estimate	RevenueReported / estimate	Reaction
Q2 FY2026 2026-07-30	2.04 / 1.60 +27.5%	$12.97B / $11.74B +10.5%	+2.79% ⁦+1.11⁩ pts vs SPY
Q1 FY2026 2026-04-30	1.58 / 1.42 +11.3%	$11.49B / $10.93B +5.1%	+5.21% ⁦+4.21⁩ pts vs SPY
Q4 FY2025 2026-02-05	1.26 / 1.23 +2.4%	$12.50B / $12.28B +1.8%	+3.30% ⁦+4.55⁩ pts vs SPY
Q3 FY2025 2025-10-30	1.63 / 1.52 +7.2%	$12.22B / $11.85B +3.1%	+7.09% ⁦+8.19⁩ pts vs SPY

Reported / estimate

Q2 FY2026 · 2026-07-30+2.79%
EPS2.04 / 1.60+27.5%
Revenue$12.97B / $11.74B+10.5%
Q1 FY2026 · 2026-04-30+5.21%
EPS1.58 / 1.42+11.3%
Revenue$11.49B / $10.93B+5.1%
Q4 FY2025 · 2026-02-05+3.30%
EPS1.26 / 1.23+2.4%
Revenue$12.50B / $12.28B+1.8%
Q3 FY2025 · 2025-10-30+7.09%
EPS1.63 / 1.52+7.2%
Revenue$12.22B / $11.85B+3.1%

Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.

Next report

2026-10-29

In 2 daysQ3 FY2026BMO

89 days ago

⁦+27.5%⁩EPS Beat

2026-07-30Q2 FY2026BMO

⁦+2.79%⁩

⁦+1.11⁩ pts vs SPY

Session ⁦2026-07-30⁩